Phase I pharmacokinetic and pharmacodynamic results of novel anti-neutropenic factor for the prevention and treatment of febrile neutropenia
Jubin, Ronald Glenn, Buontempo, Peter, Byczkowski, Daniel, Misra, Hemant K., Abuchowski, Abraham
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
ANF-Rho: A Dose-Ranging Phase I Study to Determine Safety, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
Parmar, Deven V., Byczkowski, Daniel, Jubin, Ronald G., Abuchowski, Abraham, Buontempo, Peter, Gitlin, Gerry, Boro, Michelle, Misra, Hemant K.
Published in Blood (03.12.2015)
Published in Blood (03.12.2015)
Get full text
Journal Article
A phase Ib, open‐label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end‐stage renal disease
Abu Jawdeh, Bassam G., Woodle, Ervin Steve, Leino, Abbie D., Brailey, Paul, Tremblay, Simon, Dorst, Tonya, Abdallah, Mouhamad H., Govil, Amit, Byczkowski, Daniel, Misra, Hemant, Abuchowski, Abraham, Alloway, Rita R.
Published in Clinical transplantation (01.01.2018)
Published in Clinical transplantation (01.01.2018)
Get full text
Journal Article